BIO vs RZLT · rev $651.0M vs $461.2M cap
BIO (BIO) versus Rezolute Inc (RZLT) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Rezolute Inc (RZLT) is a biotechnology company listed on NASDAQ.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
RZLT does not have a complete income-statement cache yet.
BIO currently screens at market cap $0. RZLT currently screens at market cap $461.2M.
Not investment advice. Open the BIO and RZLT stock pages for the full models.
Not investment advice.